Challenges and Innovative Solutions in Nasal Drug Delivery: From Formulation Development to Mode of Administration, 2nd Edition

Dear Colleagues,

Nasal drug administration offers a wide range of therapeutic options, including local and systemic drug delivery, brain-targeted therapy and mucosal vaccination. However, its potential has yet to be fully exploited. Widening the palette of nasally administered drugs requires the development of innovative drug formulations enhancing drug availability at the action site. Namely, formulation strategy is the key to solving drug solubility, permeation and stability issues as well as improving mucoadhesive performance. Another key aspect is the consideration of efficient drug deposition in specific nasal regions of interest, which is a prerequisite for effective nasal therapy.

This Special Issue aims to highlight the latest strategies and innovations in the development and administration of nasal drug delivery systems. We are pleased to invite you to submit your original research articles or reviews within this subject area. Research topics of interest include (but are not limited to) the following: development of innovative liquid and powder nasal drug delivery systems; nanotechnology in nasal drug delivery; in vitro/ex vivo/in vivo characterization methods in nasal formulation development; and nasal deposition studies.

I look forward to receiving your contributions.

Prof. Dr. Anita Hafner
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.